Key result
Intracoronary hyperoxemic oxygen therapy delivered to the LMCA after PCI in anterior STEMI was safe, with a 30-day NACE rate of 7.1% compared to an objective performance goal of 10.7%.
Why the study?
Is intracoronary hyperoxemic oxygen therapy delivered to the LMCA after PCI safe and feasible in patients with anterior STEMI?
Cohort (n=100)
Is intracoronary hyperoxemic oxygen therapy delivered to the LMCA after PCI safe and feasible in patients with anterior STEMI?
Intracoronary hyperoxemic oxygen therapy delivered to the LMCA for 60 minutes after PCI in anterior STEMI is feasible and has a favorable 30-day safety profile.
Answers are grounded in this paper and cite their sources.
Supports safety after LMCA delivery in anterior STEMI; leaves open efficacy in randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
David et al. (2018) conducted a cohort in anterior ST-segment elevation myocardial infarction (STEMI) (n=100). Intracoronary hyperoxemic oxygen therapy vs. Objective performance goal was evaluated on 30-day composite rate of net adverse clinical events (NACE) (death, reinfarction, clinically driven target vessel revascularization, stent thrombosis, severe heart failure, or TIMI major/minor bleeding). Intracoronary hyperoxemic oxygen therapy delivered to the LMCA after PCI in anterior STEMI was safe, with a 30-day NACE rate of 7.1% compared to an objective performance goal of 10.7%.
Synapse has enriched 10 related papers. Consider them for comparative context: